findmyKOL
Clinical trialNCT00575822TerminatedInterventional

A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD

SponsorNDO Surgical, Inc.Enrollment159Gastroesophageal Reflux Disease (GERD)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this study was to determine the effectiveness of endoscopic full-thickness plication (Plicator; NDO Surgical, Inc., Mansfield, MA) for the treatment of GERD in comparison to a sham procedure. Patients with symptomatic GERD requiring maintenance proton pump inhibitor therapy were entered into a randomized, single-blind, prospective, multicenter trial. Seventy-eight patients were randomly assigned to undergo endoscopic full-thickness restructuring of the gastric cardia with transmural suture. Eighty-one patients underwent a sham procedure. Group assignments were revealed following the 3-month evaluation. The primary endpoint was ≥ 50% improvement in GERD-HRQL score. Secondary endpoints included medication use and esophageal acid exposure. Patients achieving ≥ 50% improvement in GERD-HRQL score at 3-months versus baseline off-meds were considered responsive to their assigned procedure. Patients who failed to reach this level of improvement at 3-months were considered non-responders. Analysis of these dichotomized variables (responder/non-responder) was done using Fisher's exact test comparing the proportion of responders between the active and sham groups. Intent-to-treat analysis was also performed. The null hypothesis was that the proportion of responders was the same in both the active and sham groups. Testing was done at the 5% level of significance (alpha=0.05).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Erasme Hospital

    Brussels, Belgium

Germany
  • Klinikum Ludwigsburg, University of Heidelburg

    Heidelberg, Germany

United States
  • University of California at Irvine Medical Center

    Orange, California, United States

  • Tri Valley Gastroenterology

    San Ramon, California, United States

  • University of Colorado Health Science Center

    Denver, Colorado, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Creighton University Medical Center

    Omaha, Nebraska, United States

  • Seacoast Gastroenterology

    Exeter, New Hampshire, United States

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Lenox Hill Hospital

    New York, New York, United States

  • Nashville Medical Research and the Maria Nathanson Center of Excellence

    Nashville, Tennessee, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Virginia Mason Medical Center

    Seattle, Washington, United States

  • Digestive Health Specialists

    Tacoma, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2005
Primary completion
31 Mar 2008
Completion
31 Mar 2008
Last update posted
16 Jul 2008
Registered enrollment
159
Registry id
NCT00575822

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.